AZN241227C64000
- 2.29
- +0.19+9.05%
AstraZeneca Newsroom
Achilles Therapeutics Transfers TRACERx Data and MAP Assets to AstraZeneca in $12M Agreement
Express News | Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions
Press Release: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
London Shares Festive Ahead of Christmas Break; Vistry Slumps on Fresh Profit Warning
AstraZeneca Pulls EU Marketing Application for Lung Cancer Treatment Amid Regulatory Feedback
Astra, Daiichi Withdraw EU Application for Lung Cancer Drug
AstraZeneca Withdraws EU Application for Datopotamab Deruxtecan in Lung Cancer
Express News | US FDA: Revoked Emergency Use Authorization for AstraZeneca's Evusheld as of Dec 13 - Website
AstraZeneca PLC Stock Rises Monday, Underperforms Market
London Shares Rise; UK Economy Flatlines
Unusual Options Activity: COIN, AZN and Others Attract Market Bets, COIN V/OI Ratio Reaches 120.0
AZN's Tagrisso Gets Approval in the EU for Expanded Use in NSCLC
AstraZeneca's Blockbuster Drug Tagrisso Wins EU Nod for Non-small Cell Lung Cancer
AstraZeneca Obtains EU Approval for Tagrisso in Non-small Cell Lung Cancer Treatment
AstraZeneca's Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
Why Astrazeneca (AZN) Outpaced the Stock Market Today
AstraZeneca Hits 4-week Low
The prospects of European Medical Care stocks are complex, with USA policies and new drug trial results being the key factors.
After falling from a high position in the last few months of 2024, European Medical Care stocks face the risks of US politics and the results of high-risk new drug trials in the new year.
AstraZeneca's Alexion Inks Deal With Pan-Canadian Pharmaceutical Alliance
European Equities Traded in the US as American Depositary Rise in Wednesday Trading